Lung Cancer
Latest News
Levothyroxine dose for checkpoint inhibitor toxicity may be too high
CHICAGO – Dosing need not be automatically boosted when starting checkpoint inhibitor therapy.
Conference Coverage
Immune checkpoint inhibition in SCLC: Modest outcomes, many questions
Immune checkpoint inhibitors have activity in SCLC, but achieving more durable disease control and better survival requires greater understanding...
Conference Coverage
Patients have good recall on lung cancer screening scan benefits, not risks
NEW ORLEANS – Results suggest need for ongoing patient education beyond the initial shared decision-making encounter.
Conference Coverage
Osimertinib improves survival in advanced NSCLC
BARCELONA – Osimertinib is the first TKI to show a survival advantage over another in advanced non–small cell lung cancer, FLAURA investigators...
Article
Lung Cancer in the VA at a National Level
Conference Coverage
Mediastinal Staging for SBRT in Early NSCLC: Should it be Stratified by Tumor Size and Location?
Conference Coverage
VHA-Wide Automated Assessment of EGFR Mutation Testing in Advanced Stage, Non-Squamous, Non-Small Cell Lung Cancer (nsNSCLC)
Conference Coverage
Outcomes After Stereotactic Ablative Radiotherapy (SABR) of Early Stage Non-Small Cell Lung Cancers Without Biopsy Proven Disease
Conference Coverage
New IASLC declaration targets tobacco use among cancer patients
BARCELONA – The IASLC has released a new declaration encouraging physicians to screen all cancer patients for tobacco use and to provide tobacco...
